Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Mariko Kita"'
Autor:
Jillian R. Jaycox, Carolina Lucas, Inci Yildirim, Yile Dai, Eric Y. Wang, Valter Monteiro, Sandra Lord, Jeffrey Carlin, Mariko Kita, Jane H. Buckner, Shuangge Ma, Melissa Campbell, Albert Ko, Saad Omer, Carrie L. Lucas, Cate Speake, Akiko Iwasaki, Aaron M. Ring
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-9 (2023)
Whilst SARS-CoV-2 mRNA vaccines have demonstrated efficacy in reducing infection severity, research has shown that SARS-CoV-2 infection is associated with new autoantibodies. Whether this would also be observed during mRNA vaccination is unclear. Her
Externí odkaz:
https://doaj.org/article/3239ac58f1844ac3945c8c32a8186dce
Autor:
Karen Cerosaletti, Anya Schneider, Katharine Schwedhelm, Ian Frank, Megan Tatum, Shan Wei, Elizabeth Whalen, Carla Greenbaum, Mariko Kita, Jane Buckner, S Alice Long
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83811 (2013)
IL-2 receptor (IL-2R) signaling is essential for optimal stability and function of CD4(+)CD25(hi)FOXP3(+) regulatory T cells (Treg); a cell type that plays an integral role in maintaining tolerance. Thus, we hypothesized that decreased response to IL
Externí odkaz:
https://doaj.org/article/19b7800028a442078f9bd18de10aef3e
Autor:
Yevgeniy Yuzefpolskiy, Peter Morawski, Mitch Fahning, Cate Speake, Sandra Lord, Anu Chaudhary, Chihiro Morishima, Mark H. Wener, Mariko Kita, Lucas McCarthy, Jane H. Buckner, Daniel J. Campbell, Estelle Bettelli
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 208(7)
Multiple sclerosis (MS) is a demyelinating inflammatory disease of the CNS treated by diverse disease-modifying therapies that suppress the immune system. Severe acute respiratory syndrome coronavirus 2 mRNA vaccines have been very effective in immun
Autor:
Kazuyo Nakamura, Michihiro Kaya, Yuki Yanagisawa, Keisuke Yamamoto, Nana Takayashiki, Hirotoshi Ukita, Mariko Nagura, Kaori Sugiue, Mariko Kitajima, Kumi Hirano, Hiroki Ishida, Chiharu Onoda, Yutaka Kobayashi, Eiji Nakatani, Keiichi Odagiri, Takaya Suzuki
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Bone metastases are frequently observed in advanced cancer, and bone modifying agents are used to prevent or treat skeletal-related events. Zoledronic acid is contraindicated in patients with severe renal impairment (Ccr
Externí odkaz:
https://doaj.org/article/68653e29483f4025a3d904e57c4852f2
Autor:
Jennifer Graves, Adrian Pace, Maria Pia Sormani, Devon S. Conway, Bianca Weinstock-Guttman, Frederick E. Munschauer, Corey C. Ford, Vernon Rowe, Jana Lizrova Preiningerova, Shiv Saidha, Radek Ampapa, Jens Kuhle, Harold L. Moses, Claire S Riley, Tobias Derfuss, Lilyana Amezcua, Joshua Barton, Kottil Rammohan, Pierre Duquette, Thomas Leist, Alexander Rae-Grant, Evanthia Bernitsas, Myla D. Goldman, R. Talab, Jerry S. Wolinsky, Nina De Klippel, Guillermo Izquierdo Ayuso, Bridget Bagert, Virginia Devonshire, Mariko Kita, Hayrettin Tumani, Bhatia Perminder, Scott D. Newsome, Paul S. Giacomini, Frédéric Sedel, Jan Lycke, M. S. Freedman, Stewart Webb, Sanjay Yathiraj, Agata Klosek, Stephen Krieger, Edward Fox, Malgorzata Zajda, Eva Meluzinova, Valerie J Block, Lluís Ramió-Torrentà, John R. Corboy, Aaron E. Miller, Xavier Montalban, Mark A. Agius, Michelle L Apperson, Patricia K. Coyle, Giancarlo Comi, Jose Enrique Martinez Rodriguez, Daniela Rau, Derrick Robertson, Elias Hamp Birte, Douglas L. Arnold, Fred D. Lublin, Galina Vorobeychik, Benjamin Greenberg, Mathias Buttmann, Daniel Bandari, Ludivine Witkowski, Sharon G. Lynch, Victoria Fernandez Sanchez, Jonathan Calkwood, Maria Satori, Tania Kuempfel, Rana K. Zabad, J. Marc Girard, Bruce A.C. Cree, Ahmed T. Toosy, Don J. Mahad, Bruce A. Cohen, Jozef Koscielniak, Jonathan Carter, Daniel Selchen, Paul Friedemann, Sharon Stoll, Fryze Waldemar, Gerd Reifschneider, Mark S. Freedman, Gary Cutter, Franz Fazekas, Robert T. Naismith, Marta Vachova, Richard MacDonell, Mary Ann Picone, Gavin Giovannoni, Randall Trudell, Barbara Willekens, Orhan Aktas, Mark Marriott, Roger McKelvey, Bruce C.A. Cree, Christopher Severson, Rafael Arroyo Gonzalez, Kyle Smoot, Murat Terzi, Joanna Cooper, Lou Brundin, Hans-Peter Hartung, Piotr Sokolowski, Joe Guadagno, Stephen C. Reingold, Klaus Schmierer, Guy Laureys, Robert P. Lisak, Lawrence Samkoff, Carlo Pozzilli, Celia Oreja Guevara, Mitchel Freedman, Anthony T. Reder
Publikováno v:
The lancet neurology
Background: There is an unmet need to develop therapeutic interventions directed at the neurodegeneration that underlies progression in multiple sclerosis. High-dose, pharmaceutical-grade biotin (MD1003) might enhance neuronal and oligodendrocyte ene
Autor:
Jane H. Buckner, Donna M. Shows, Katherine Schwedhelm, Janice Chen, Jerill Thorpe, Mariko Kita, James D. Lord, S. Alice Long
Publikováno v:
Clinical Immunology. 193:24-32
Integrin alpha4/beta7 on circulating lymphocytes identifies them as gut-tropic, and can be targeted by the humanized antibody vedolizumab to treat inflammatory bowel disease (IBD). We found lymphocytes expressing alpha4/beta7 were significantly more
Autor:
Claudia Prada, Mariko Kita, Pavle Repovic, Daniel S. Bandari, Emily Riser, Bhupendra O. Khatri, Sherrill Loring, Jeffrey Greenstein, Nick Everage, Guy J. Buckle, Katherine Riester, Mark Gudesblatt, Irene Koulinska, Bianca Weinstock-Guttman, Ben Thrower, Monica Mann
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background In patients treated with dimethyl fumarate, absolute lymphocyte count decline typically occurs during the first year and then plateaus; early drops have been associated with the development of severe prolonged lymphopenia. Objective We inv
Autor:
Mariko, Kita, Robert J, Fox, Ralf, Gold, Gavin, Giovannoni, J Theodore, Phillips, Sujata P, Sarda, Jessica, Kong, Vissia, Viglietta, Sarah I, Sheikh, Macaulay, Okwuokenye, Ludwig, Kappos
Publikováno v:
Clinical therapeutics. 40(5)
Autor:
Jacqueline A Quandt, Christina J. Azevedo, Etty Tika Benveniste, Patricia K. Coyle, Emmanuelle Waubant, Yunyan Zhang, Valerie Block, Vijay Yadav, Elisabeth Gulowsen Celius, Amy Waldman, Matilde Inglese, Jill Conway, Helen Tremlett, Olga Ciccarelli, Sandra Vukusic, Elisabeth Maillart, Christine Lebrun-Frenay, Brenda Banwell, Ellen M. Mowry, Seema K. Tiwari-Woodruff, Cornelia Laule, Jodie M Burton, Laure Michel, Afsaneh Shirani, Tanuja Chitnis, Elaine Kingwell, Myla D. Goldman, Nasrin Asgari, Rana Zabad, Carolina Ionete, Nancy L. Monson, Hanne F. Harbo, Naila Makhani, Carrie M. Hersh, Tamara Castillo-Triviño, Claire S Riley, Ingrid van der Mei, Anneke van der Walt, Annette Langer-Gould, Ruth Ann Marrie, Eva Havrdova, Lauren B. Krupp, Katherine Whartenby, Maria Pia Amato, Rhonda R. Voskuhl, Judith B. Grinspan, Vilija Jokubaitis, Monica J. Carson, Bibi Bielekova, Elizabeth Crabtree, Jiwon Oh, Le H. Hua, Julia Pakpoor, Mariko Kita, Fiona Costello, Lisa F. Barcellos, Georgina Arrambide, Margaret Burnett, Fabienne Brilot-Turville, Luanne M. Metz, Emmanuelle Leray, Ann Yeh, Maria Petracca, Prue Plummer, Robyn M. Lucas, Dalia Dimitri, Caroline Papeix, Leslie Benson, Wendy B. Macklin, Sarah A Morrow, Jennifer Graves, Soe Mar, Carolyn Bevan, Frauke Zipp, Jacqueline Palace, Ruth Dobson, Idanis Berrios Morales, Rosa Cortese, Lilyana Amezcua, Joan Goverman, Orla Gray, Mar Tintoré, Kerstin Hellwig, Katerina Akassoglou, Jennifer Orthmann Murphy, Penelope Smyth, Teri Schreiner, Nancy L. Sicotte, May H. Han, Maria Trojano, Mary Rensel, Wendy Gilmore, Laura Airas, Laura Piccio, Silvia Tenembaum, Rebecca Spain, Claudia F. Lucchinetti, Jana Lizrova Preiningerova, Maria Pia Sormani, Giulia Bommarito, Riley Bove, Ilana Katz Sand, Dina A. Jacobs, Bianca Weinstock-Guttman, Eve E Kelland, Leigh Charvet, Catherine Lubetzki, Anne H. Cross, Erin E. Longbrake
Publikováno v:
Annals of Neurology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b41e7188bc9900ffe25ed7205b08795a
http://hdl.handle.net/11365/1192033
http://hdl.handle.net/11365/1192033
Autor:
J. Theodore Phillips, Katherine Dawson, Sarah Sheikh, Michael Hutchinson, Mariko Kita, Ralf Gold, Douglas L. Arnold, Vissia Viglietta, Minhua Yang, Krzysztof Selmaj, Robert J. Fox, David Miller, Ray Zhang, Amit Bar-Or
Publikováno v:
Annals of Clinical and Translational Neurology
Objective Obtain a more precise estimate of the efficacy of delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) in relapsing multiple sclerosis (MS) and examine the consistency of DMF's effects across patient subgroups stratif